Pancagen

Pancragen peptide primarily supports pancreatic health by enhancing insulin production, glucose regulation, and digestive enzyme secretion.

Derived from the synthetic tetrapeptide sequence Lys-Glu-Asp-Trp (KEDW), it acts as a bioregulator that penetrates pancreatic cells to modulate gene expression, promoting tissue repair and reducing age-related cellular decline.

Key benefits identified in research and clinical contexts include:

• Improved Glucose Control: Studies indicate it can significantly decrease fasting blood sugar, reduce insulin resistance, and normalize plasma insulin dynamics in both diabetic and pre-diabetic models.
• Pancreatic Regeneration: The peptide upregulates critical transcription factors (e.g., Pdx1, Pax6) and proliferation markers (PCNA, Ki67) while downregulating pro-apoptotic proteins (p53), facilitating the repair of damaged islet and acinar cells.
• Enhanced Metabolic and Digestive Function: By boosting the synthesis of digestive enzymes, Pancragen aids in nutrient absorption, reduces symptoms of exocrine insufficiency like bloating, and supports overall metabolic efficiency.
• Long-Term Cellular Protection: Its effects, including anti-inflammatory and anti-aging properties, have been observed to persist for weeks after treatment cessationin animal and human trials.